These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8255496)

  • 21. Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin.
    Haupt WF; Rosenow F; van der Ven C; Borberg H; Pawlik G
    Ther Apher; 1997 Feb; 1(1):55-7. PubMed ID: 10225782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC; Annane D; Chevret S; Chillet P; Gajdos P
    Presse Med; 1996 Oct; 25(31):1516-22. PubMed ID: 8958883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin.
    Haupt WF; Rosenow F; van der Ven C; Borberg H; Pawlik G
    J Neurol Sci; 1996 May; 137(2):145-9. PubMed ID: 8782169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2010 Jun; (6):CD002063. PubMed ID: 20556755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Guillain-Barré syndrome: listening carefully to the music before jumping on the bandwagon.
    Weinstein R
    Transfus Sci; 1994 Dec; 15(4):490-5. PubMed ID: 10155569
    [No Abstract]   [Full Text] [Related]  

  • 27. Relapses in the Guillain-Barré syndrome after treatment with intravenous immune globulin or plasma exchange.
    Romano JG; Rotta FT; Potter P; Rosenfeld V; Santibanez R; Rocha B; Bradley WG
    Muscle Nerve; 1998 Oct; 21(10):1327-30. PubMed ID: 9736064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between IVIg and plasma exchange in Guillain-Barré syndrome: a review and decision analysis of the two treatment modalities.
    Dawson WB; Phillips LH
    Clin Neuropharmacol; 1995 Oct; 18(5):377-90. PubMed ID: 8665552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Guillain-Barré syndrome in adults: role of plasma exchange].
    Raphael JC; Chevret S; Auriant I; Sharshar T; Bouget J; Bolgert F
    Rev Med Interne; 1998 Jan; 19(1):60-8. PubMed ID: 9775118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome.
    Fasanaro AM; Pizza V; Stella L
    Acta Neurol (Napoli); 1992; 14(4-6):369-80. PubMed ID: 1293980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin in two children with Guillain-Barré syndrome.
    Notarangelo LD; Duse M; Tiberti S; Guarneri B; Brunori A; Negrini A; Ugazio AG
    Eur J Pediatr; 1993 Apr; 152(4):372-4. PubMed ID: 8482293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; Doorn PA
    Cochrane Database Syst Rev; 2004; (1):CD002063. PubMed ID: 14973982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome.
    Ravasio A; Pasquinelli M; Currò Dossi B; Neri W; Guidi C; Gessaroli M; Rasi F; Fabbri R; Mazzini G; Rebucci GG
    Ital J Neurol Sci; 1995 Oct; 16(7):487-92. PubMed ID: 8749707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA
    Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K; Hattori N; Sobue G
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002063. PubMed ID: 16437439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunoglobulins or plasma exchange? Guillain-Barré syndrome: indications for plasma exchange and immunoglobulins].
    Raphaël JC; Chevret S; Jars-Guincestre MC; Chastang C; Gajdos P
    Ann Med Interne (Paris); 1993; 144(8):526-31. PubMed ID: 8179242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.